NDC 64980-175

CARISOPRODOL and ASPIRIN

Carisoprodol And Aspirin

CARISOPRODOL and ASPIRIN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Rising Pharmaceuticals, Inc.. The primary component is Carisoprodol; Aspirin.

• Product ID: 64980-175_9d8b08a9-02c8-4b02-9e0e-a24b90d7a7e0
• NDC: 64980-175
• Product Type: Human Prescription Drug
• Proprietary Name: CARISOPRODOL and ASPIRIN
• Generic Name: Carisoprodol And Aspirin
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2010-01-07
• Marketing Category: ANDA / ANDA
• Application Number: ANDA040832
• Labeler Name: Rising Pharmaceuticals, Inc.
• Substance Name: CARISOPRODOL; ASPIRIN
• Active Ingredient Strength: 200 mg/1; mg/1
• Pharm Classes: Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 64980-175-01

100 TABLET in 1 BOTTLE (64980-175-01)

• Marketing Start Date: 2010-01-07
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 64980-175-01 [64980017501]

CARISOPRODOL AND ASPIRIN TABLET

• Marketing Category: ANDA
• Application Number: ANDA040832
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2012-06-13
• Marketing End Date: 2014-04-01
• Inactivation Date: 2019-11-13
• Reactivation Date: 2019-12-26

NDC 64980-175-05 [64980017505]

CARISOPRODOL AND ASPIRIN TABLET

• Marketing Category: ANDA
• Application Number: ANDA040832
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2012-06-13
• Marketing End Date: 2014-04-01
• Inactivation Date: 2019-11-13
• Reactivation Date: 2019-12-26

Drug Details

Active Ingredients

Ingredient	Strength
CARISOPRODOL	200 mg/1

OpenFDA Data

• SPL SET ID: 9d8b08a9-02c8-4b02-9e0e-a24b90d7a7e0
• Manufacturer:
  • Rising Pharmaceuticals, Inc.
• UNII:
  • R16CO5Y76E
  • 21925K482H
• RxNorm Concept Unique ID - RxCUI:
  • 197447
• Pharm Class PE:
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
• PHarm Class EPC:
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
• UPC Code:
  • 0364980175012
• NUI Code:
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

Pharmacological Class

• Centrally-mediated Muscle Relaxation [PE]
• Muscle Relaxant [EPC]
• Cyclooxygenase Inhibitors [MoA]
• Decreased Prostaglandin Production [PE]
• Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
• Nonsteroidal Anti-inflammatory Drug [EPC]
• Platelet Aggregation Inhibitor [EPC]
• Decreased Platelet Aggregation [PE]

Medicade Reported Pricing

64980017501 CARISOPRODL-ASPIRIN 200-325 MG

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "CARISOPRODOL and ASPIRIN" or generic name "Carisoprodol And Aspirin"

NDC	Brand Name	Generic Name
0185-0724	Carisoprodol and Aspirin	Carisoprodol and Aspirin
21695-570	Carisoprodol and Aspirin	Carisoprodol and Aspirin
23155-145	Carisoprodol and Aspirin	Carisoprodol and Aspirin
64980-175	CARISOPRODOL and ASPIRIN	CARISOPRODOL and ASPIRIN